English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

This app aggregates multiple eGFR calculators into a single app and integrates text-based contrast imaging protocol decision support. Data for both CIN and NSF for respective contrast media subclasses are conveniently centralized and summarized, with tailored presentation of evidence-based risk estimates and suggested protocol guidance for a given eGFR. This can facilitate protocolling decisions for patients with borderline renal function by providing a single reference for both MR and CT contrast agents, which is unique among app-based eGFR calculators. Cons: Unclear or not explicitly stated what risk prediction model is implemented for estimation of NSF and CIN risk for a given eGFR. Although targeted to all Bhealthcare professionals in their daily practices, including nurses, radiology technologists, medical students, interns, residents, clinicians, surgeons, oncologists, nephrologists, urologists, gastroenterologists, radiologists and other medical specialists,^ the potential beneficiaries of this app are primarily the radiologist and technologist involved in study protocolling, and for these users, the cost of the app may be justified. At a glance: Convenient aggregation of multiple eGFR calculators, integrated with a risk prediction model for NSF and CIN and text-based decision support for guidance in choosing between subclasses of contrast media. Although targeted to all healthcare professionals, the potential beneficiaries of this app are primarily the radiologist and technologist involved in study protocolling, and for these users, the cost of the app may be justified. * James Shin jjs7005@med.cornell.edu

NSF vs. CIN: Aggregated Screening, Safety, and Protocol Tools for Contrast Imaging in the Setting of Renal Insufficiency